Savara, Inc. (SVRA)
4.22
-0.32
(-7.05%)
USD |
NASDAQ |
Oct 23, 16:00
4.28
+0.06
(+1.42%)
After-Hours: 20:00
Savara Price : 4.22 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 4.52 | 4.58 | 4.13 | 4.22 | 2.829M |
| Oct 22, 2026 | 4.65 | 4.75 | 4.45 | 4.54 | 2.710M |
| Oct 21, 2026 | 4.79 | 4.945 | 4.66 | 4.67 | 2.087M |
| Oct 20, 2026 | 4.64 | 4.99 | 4.60 | 4.76 | 4.422M |
| Oct 19, 2026 | 4.53 | 4.705 | 4.495 | 4.63 | 1.564M |
| Oct 16, 2026 | 4.75 | 4.77 | 4.44 | 4.45 | 2.237M |
| Oct 15, 2026 | 4.76 | 4.90 | 4.72 | 4.74 | 1.691M |
| Oct 14, 2026 | 4.71 | 4.82 | 4.65 | 4.76 | 2.574M |
| Oct 13, 2026 | 4.84 | 5.02 | 4.76 | 4.78 | 3.742M |
| Oct 12, 2026 | 4.93 | 5.00 | 4.81 | 4.84 | 1.307M |
| Oct 09, 2026 | 4.82 | 4.975 | 4.81 | 4.92 | 1.529M |
| Oct 08, 2026 | 4.85 | 4.92 | 4.635 | 4.83 | 2.516M |
| Oct 07, 2026 | 4.74 | 5.05 | 4.69 | 4.88 | 2.415M |
| Oct 06, 2026 | 4.82 | 4.84 | 4.60 | 4.65 | 2.291M |
| Oct 05, 2026 | 4.85 | 4.915 | 4.71 | 4.78 | 2.863M |
| Oct 02, 2026 | 5.10 | 5.16 | 4.765 | 4.81 | 2.653M |
| Oct 01, 2026 | 5.15 | 5.24 | 5.03 | 5.045 | 2.550M |
| Sep 30, 2026 | 5.15 | 5.24 | 5.05 | 5.16 | 6.052M |
| Sep 29, 2026 | 5.07 | 5.19 | 5.00 | 5.08 | 2.035M |
| Sep 28, 2026 | 4.97 | 5.155 | 4.86 | 5.07 | 4.372M |
| Sep 25, 2026 | 5.08 | 5.18 | 4.87 | 5.00 | 2.452M |
| Sep 24, 2026 | 5.03 | 5.085 | 4.884 | 5.07 | 2.500M |
| Sep 23, 2026 | 5.30 | 5.34 | 4.90 | 5.00 | 3.354M |
| Sep 22, 2026 | 5.52 | 5.525 | 5.29 | 5.30 | 1.414M |
| Sep 21, 2026 | 5.44 | 5.51 | 5.36 | 5.45 | 1.312M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 156.04 |
| Insmed, Inc. | 93.39 |
| United Therapeutics Corp. | 587.50 |
| Vertex Pharmaceuticals, Inc. | 523.93 |
| ACADIA Pharmaceuticals, Inc. | 19.73 |
Price Related Metrics
| PEG Ratio | -0.5903 |
| Price to Book Value | 6.034 |
| Earnings Yield | -13.66% |
| Market Cap | 866.79M |
| PEGY Ratio | -0.5903 |